Publication details

Molecular characterization of the rare translocation t(3;10)(q26;q21) in an acute myeloid leukemia patient

Authors

JANCUSKOVA T PLACHY R ZEMANKOVA L HARDEKOPF DW ŠTIKA Jiří ZEJSKOVA L PRAULICH I KREUZER KA ROTHE A OTHMAN MAK KOSYAKOVA N PEKOVA S

Year of publication 2014
Type Article in Periodical
Magazine / Source MOLECULAR CYTOGENETICS
Citation
Doi http://dx.doi.org/10.1186/1755-8166-7-47
Keywords AML; MECOM; Chromosomal microdissection; Next-generation sequencing; Molecular marker
Description Background: In acute myeloid leukemia (AML), the MDS1 and EVI1 complex locus - MECOM, also known as the ecotropic virus integration site 1 - EVI1, located in band 3q26, can be rearranged with a variety of partner chromosomes and partner genes. Here we report on a 57-year-old female with AML who presented with the rare translocation t(3;10) (q26;q21) involving the MECOM gene. Our aim was to identify the fusion partner on chromosome 10q21 and to characterize the precise nucleotide sequence of the chromosomal breakpoint. Methods: Cytogenetic and molecular-cytogenetic techniques, chromosome microdissection, next generation sequencing, long-range PCR and direct Sanger sequencing were used to map the chromosomal translocation. Results: Using a combination of cytogenetic and molecular approaches, we mapped the t(3;10)(q26;q21) to the single nucleotide level, revealing a fusion of the MECOM gene (3q26.2) and C10orf107 (10q21.2). Conclusions: The approach described here opens up new possibilities in characterizing acquired as well as congenital chromosomal aberrations. In addition, DNA sequences of chromosomal breakpoints may be a useful tool for unique molecular minimal residual disease target identification in acute leukemia patients.

You are running an old browser version. We recommend updating your browser to its latest version.

More info